Skip to main navigation

About Xeris
Products
- Overview
- Gvoke
- Recorlev
- Keveyis
Research & Development
Investors
Careers
Contact Us

News Releases
Events & Presentations

Event Details

Xeris Biopharma First Quarter 2023 Financial Results Call

May 9, 2023 at 8:30 AM EDT

Click here for webcast

Request email alerts

Gvoke^®, Gvoke HypoPen^®, XeriSol^TM, XeriJect^TM, Xeris Pharmaceuticals^®, Ogluo^®, Keveyis^®, Recorlev^®, XerisCareConnection^TM and their associated logos are trademarks owned by or licensed to Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc. All other trademarks are the property of their respective owners.

Contact us
Terms of use
Privacy policy
Privacy shield policy
Financial conflict of interest policy

Copyright ©2023 Xeris Biopharma Holdings, Inc. All rights reserved. US-CORP-22-00084

Search

Search this site